Capital Analysts, LLC Astrazeneca PLC Transaction History
Capital Analysts, LLC
- $2.49 Billion
- Q4 2024
A detailed history of Capital Analysts, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Analysts, LLC holds 951 shares of AZN stock, worth $71,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
951
Previous 930
2.26%
Holding current value
$71,819
Previous $73,000
15.07%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.56 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.1 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.8 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...